• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估一种新型粪便抗原检测试剂检测克拉霉素耐药幽门螺杆菌的方法。

Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent.

机构信息

Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga-shi, Saga, 849-8501, Japan.

Division of Gastroenterology, Department of Internal Medicine, Imamura Hospital, Tosu, Japan.

出版信息

BMC Gastroenterol. 2020 Nov 23;20(1):397. doi: 10.1186/s12876-020-01549-9.

DOI:10.1186/s12876-020-01549-9
PMID:33228552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7682763/
Abstract

BACKGROUND

The resistance rate of Helicobacter pylori to clarithromycin (CAM) is high among infected children in Japan. Therefore, a new method for detecting CAM-resistant H. pylori using a minimally invasive technique is strongly desired. We aimed to investigate the clinical usefulness of our newly developed nested polymerase chain reaction-quenching probe (Nested PCR-QP) method using stool specimens.

METHODS

We first evaluated our method using a residual solution of the H. pylori stool antigen test for adolescents. Then, we evaluated our method using culture testing for adults.

RESULTS

Among 57 middle school students with H. pylori, the Nested PCR-QP test results of 53 (90.3%) were able to be analyzed. A total of 28 students had CAM resistance mutations. We found a genetic mutation in 28 students and no mutation in 23 students, and these results were consistent with those of PCR-direct sequencing. In the 23 adults who were diagnosed with H. pylori infection using the rapid urease test and culture testing, we were able to use Nested PCR-QP for analyzing 21 adults who tested positive in the stool H. pylori antigen test. The results obtained for all 21 adults were consistent with those obtained via the drug susceptibility test.

CONCLUSIONS

Our novel method could be useful for non-invasively detecting CAM resistance mutations in H. pylori. This may help select a drug to reduce eradication failure rates against H. pylori. Trial registration This study was registered with the University Hospital Medical Information Network Clinical Trials Registry (no. UMIN000030632, https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034977 ) on 29 December 2017.

摘要

背景

在日本,感染儿童的幽门螺杆菌对克拉霉素(CAM)的耐药率很高。因此,强烈需要一种使用微创技术检测 CAM 耐药幽门螺杆菌的新方法。我们旨在使用粪便标本研究我们新开发的嵌套聚合酶链反应-淬灭探针(Nested PCR-QP)方法的临床实用性。

方法

我们首先使用青少年幽门螺杆菌粪便抗原检测的残留溶液评估我们的方法。然后,我们使用成人培养检测评估我们的方法。

结果

在 57 名中学生中,53 名(90.3%)的 Nested PCR-QP 检测结果可进行分析。共有 28 名学生有 CAM 耐药突变。我们在 28 名学生中发现了遗传突变,在 23 名学生中没有发现突变,这些结果与 PCR-直接测序的结果一致。在通过快速尿素酶试验和培养试验诊断为幽门螺杆菌感染的 23 名成年人中,我们能够使用 Nested PCR-QP 分析 21 名粪便幽门螺杆菌抗原检测呈阳性的成年人。所有 21 名成年人的结果均与药敏试验结果一致。

结论

我们的新方法可用于非侵入性地检测幽门螺杆菌中的 CAM 耐药突变。这可能有助于选择药物来降低幽门螺杆菌根除失败率。

试验注册

本研究于 2017 年 12 月 29 日在大学医院医疗信息网络临床试验注册中心(注册号 UMIN000030632,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034977)注册。

相似文献

1
Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent.评估一种新型粪便抗原检测试剂检测克拉霉素耐药幽门螺杆菌的方法。
BMC Gastroenterol. 2020 Nov 23;20(1):397. doi: 10.1186/s12876-020-01549-9.
2
Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.粪便标本检测克拉霉素耐药幽门螺杆菌在接受根除治疗的年轻成年人中的应用。
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12396. Epub 2017 May 22.
3
Clinical evaluation of a novel molecular diagnosis kit for detecting Helicobacter pylori and clarithromycin-resistant using intragastric fluid.采用胃内液检测幽门螺杆菌和克拉霉素耐药的新型分子诊断试剂盒的临床评估。
Helicobacter. 2022 Dec;27(6):e12933. doi: 10.1111/hel.12933. Epub 2022 Oct 20.
4
Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens.用于检测幽门螺杆菌感染及同时对粪便和活检标本进行克拉霉素敏感性检测的新型实时聚合酶链反应检测法。
J Clin Microbiol. 2004 Oct;42(10):4512-8. doi: 10.1128/JCM.42.10.4512-4518.2004.
5
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori.建立一种巢式不对称聚合酶链反应方法以测定幽门螺杆菌对克拉霉素的耐药性。
World J Gastroenterol. 2016 Jul 7;22(25):5822-30. doi: 10.3748/wjg.v22.i25.5822.
6
Smart Gene™ as an effective non-invasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation.SmartGene™ 是一种有效的非侵入性即时检测方法,用于检测幽门螺杆菌克拉霉素耐药突变。
J Gastroenterol Hepatol. 2022 Sep;37(9):1719-1725. doi: 10.1111/jgh.15887. Epub 2022 May 23.
7
Polymerase chain reaction--restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample.利用粪便样本对儿童克拉霉素耐药幽门螺杆菌感染进行聚合酶链反应-限制性片段长度多态性分析
Helicobacter. 2005 Jun;10(3):205-13. doi: 10.1111/j.1523-5378.2005.00312.x.
8
[Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children].[儿童幽门螺杆菌对克拉霉素耐药的患病率及机制]
Zhonghua Er Ke Za Zhi. 2004 Nov;42(11):850-3.
9
Real-Time Polymerase Chain Reaction for the Detection of and Clarithromycin Resistance.实时聚合酶链反应检测和克拉霉素耐药性。
Gut Liver. 2023 May 15;17(3):375-381. doi: 10.5009/gnl220076. Epub 2022 Jul 20.
10
Detection of clarithromycin-resistant Helicobacter pylori by stool PCR in children: a comprehensive review of literature.粪便 PCR 检测儿童克拉霉素耐药幽门螺杆菌:文献综述。
Helicobacter. 2013 Apr;18(2):89-101. doi: 10.1111/hel.12016. Epub 2012 Oct 12.

引用本文的文献

1
Accuracy of Fecal Polymerase Chain Reaction Testing in Clarithromycin-Resistant Helicobacter Pylori: A Systematic Review and Meta-Analysis.粪便聚合酶链反应检测对克拉霉素耐药幽门螺杆菌的准确性:一项系统评价和荟萃分析。
Clin Transl Gastroenterol. 2025 Feb 1;16(2):e00792. doi: 10.14309/ctg.0000000000000792.
2
The prevalence of clarithromycin-resistant isolates: a systematic review and meta-analysis.克拉霉素耐药分离株的流行率:系统评价和荟萃分析。
PeerJ. 2023 Mar 30;11:e15121. doi: 10.7717/peerj.15121. eCollection 2023.
3
The State of the Art of Molecular Fecal Investigations for () Antibiotic Resistances.分子粪便检测在()抗生素耐药性方面的最新进展。
Int J Mol Sci. 2023 Feb 22;24(5):4361. doi: 10.3390/ijms24054361.
4
Commentary: Tailored therapy for eradication: A systematic review and meta-analysis.评论:根除的个性化治疗:一项系统评价与荟萃分析。
Front Pharmacol. 2022 Dec 20;13:1090776. doi: 10.3389/fphar.2022.1090776. eCollection 2022.
5
Clinical evaluation of a novel molecular diagnosis kit for detecting Helicobacter pylori and clarithromycin-resistant using intragastric fluid.采用胃内液检测幽门螺杆菌和克拉霉素耐药的新型分子诊断试剂盒的临床评估。
Helicobacter. 2022 Dec;27(6):e12933. doi: 10.1111/hel.12933. Epub 2022 Oct 20.
6
Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting .新型粪便抗原 Bioluminescent 酶免疫检测试验用于检测. 的临床评估
Can J Gastroenterol Hepatol. 2022 Apr 21;2022:5571542. doi: 10.1155/2022/5571542. eCollection 2022.
7
Diagnosis of Infection and Recent Advances.感染的诊断及最新进展
Diagnostics (Basel). 2021 Jul 21;11(8):1305. doi: 10.3390/diagnostics11081305.

本文引用的文献

1
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan.日本初高中生幽门螺杆菌感染患者采用沃诺拉赞为基础的双联疗法联合阿莫西林治疗的临床影响。
J Gastroenterol. 2020 Oct;55(10):969-976. doi: 10.1007/s00535-020-01709-4. Epub 2020 Jul 14.
2
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.《儿童幽门螺杆菌感染管理的 JSPGHAN 指南更新版》。
Pediatr Int. 2020 Dec;62(12):1315-1331. doi: 10.1111/ped.14388.
3
A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report.佐贺县初中学生中幽门螺杆菌筛查和治疗计划以消除胃癌:初步报告。
J Gastroenterol. 2019 Aug;54(8):699-707. doi: 10.1007/s00535-019-01559-9. Epub 2019 Feb 15.
4
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis.幽门螺杆菌根除对胃癌发病率的影响:系统评价和荟萃分析。
Gastric Cancer. 2019 May;22(3):435-445. doi: 10.1007/s10120-018-0876-0. Epub 2018 Sep 11.
5
Diagnostic Accuracy of Latex Agglutination Turbidimetric Immunoassay in Screening Adolescents for Helicobacter pylori Infection in Japan.乳胶凝集比浊免疫测定法在日本青少年幽门螺杆菌感染筛查中的诊断准确性。
Digestion. 2018;98(2):75-80. doi: 10.1159/000487184. Epub 2018 Apr 26.
6
Epidemiology of and CagA-Positive Infections and Global Variations in Gastric Cancer.和 CagA 阳性感染的流行病学以及胃癌的全球变异。
Toxins (Basel). 2018 Apr 19;10(4):163. doi: 10.3390/toxins10040163.
7
Randomized controlled trial: PPI-based triple therapy containing metronidazole versus clarithromycin as first-line treatment for Helicobacter pylori in adolescents and young adults in Japan.随机对照试验:在日本,含甲硝唑的基于质子泵抑制剂的三联疗法与含克拉霉素的三联疗法作为青少年和年轻成人幽门螺杆菌的一线治疗对比研究
J Infect Chemother. 2018 Jul;24(7):538-543. doi: 10.1016/j.jiac.2018.02.013. Epub 2018 Mar 28.
8
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.全球范围内采用 H. pylori 检测-治疗根除疗法的趋势与胃癌预防策略
J Gastroenterol. 2018 Mar;53(3):354-361. doi: 10.1007/s00535-017-1407-1. Epub 2017 Nov 14.
9
Estimation of lifetime cumulative incidence and mortality risk of gastric cancer.胃癌终生累积发病率和死亡风险的估计。
Jpn J Clin Oncol. 2017 Nov 1;47(11):1097-1102. doi: 10.1093/jjco/hyx128.
10
Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.日本对胃癌的幽门螺杆菌根除治疗的影响。
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12415. Epub 2017 Aug 3.